GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly innovation in how we approach type 2 diabetes . These new drugs help stimulating the body’s inherent GLP-1 process, which https://declanmeqp516929.dsiblogger.com/75074887/glp-1-a-major-advance-in-blood-sugar-management